Literature DB >> 24620935

Paraoxonase 1 lactonase activity and distribution in the HDL subclasses in the cord blood.

Alejandro Gugliucci, Masahide Numaguchi, Russell Caccavello, Satoshi Kimura.   

Abstract

OBJECTIVES: Paraoxonase 1 (PON1) is a lactonase with important antioxidant and immunoprotective properties. We hypothesized that PON1 lactonase activity, PON1, and high-density lipoprotein (HDL) subclasses distribution are different in neonates than in adults.
MATERIAL AND METHODS: We studied 83 healthy term neonates (34 males and 49 females) who were born by spontaneous, uncomplicated vaginal delivery. The study also included 17 paired maternal blood samples as well as 20 non-pregnant women collected for comparison. Total and free PON1 lactonase and arylesterase activity, HDL subclasses, PON1, and apolipoprotein distribution in the subclasses were assayed.
RESULTS: PON1 arylesterase activity in the cord blood represented 37% ± 4 of the maternal activity, whereas the PON1 lactonase activity amounted to only 23% ± 5 of the maternal activity. The free arylesterase and lactonase activities were higher in the cord blood by 16 and 36%, respectively. There is a 65% lower HDL2b PON1 in the cord blood than in the maternal serum. When the Lipoprint HDL subclasses were assayed, the neonates showed a larger content (52% higher) of very large HDL as well as a characteristic peak in the middle-sized HDL5 which is unremarkable in the mothers.
CONCLUSION: The novel findings of this study are that the neonates have lower PON1 lactonase activity, higher free PON1, different distributions of PON1 in the HDL subclasses as compared with their mother and adults as well as a distinctive HDL subclass lipid profile. Our data also suggest that the neonate HDL is enriched with an intermediate-sized (and/or less charged HDL) that is also rich in active PON1.

Entities:  

Keywords:  Arylesterase; Cardiovascular risk; High-density lipoprotein subclasses; Lactonase; Newborn HDL composition; PON1

Mesh:

Substances:

Year:  2014        PMID: 24620935      PMCID: PMC6837574          DOI: 10.1179/1351000213Y.0000000081

Source DB:  PubMed          Journal:  Redox Rep        ISSN: 1351-0002            Impact factor:   4.412


  37 in total

1.  The free fraction of paraoxonase 1 is not increased in patients with end stage renal disease undergoing hemodialysis.

Authors:  Alejandro Gugliucci; John Schulze; Eriko Kinugasa; Hiroaki Ogata; Satoshi Kimura
Journal:  Clin Chim Acta       Date:  2008-12-25       Impact factor: 3.786

Review 2.  Metabolic interrelationships of HDL subclasses.

Authors:  R M Krauss; A V Nichols
Journal:  Adv Exp Med Biol       Date:  1986       Impact factor: 2.622

3.  The pattern of major serum apolipoproteins during the early neonatal period.

Authors:  F Stozický; P Slabý; L Voleniková
Journal:  Acta Paediatr Scand       Date:  1982-03

Review 4.  Antiatherogenic function of HDL particle subpopulations: focus on antioxidative activities.

Authors:  Anatol Kontush; M John Chapman
Journal:  Curr Opin Lipidol       Date:  2010-08       Impact factor: 4.776

5.  Maternal active or passive smoking causes oxidative stress in cord blood.

Authors:  Ali Aycicek; Abdullah Ipek
Journal:  Eur J Pediatr       Date:  2007-02-13       Impact factor: 3.183

6.  Familial history of cardiovascular disease and blood lipid pattern in newborn infants.

Authors:  R Bellù; M T Ortisi; C Agostoni; P Incerti; R Besana; E Riva; M Giovannini
Journal:  Acta Paediatr       Date:  1992-01       Impact factor: 2.299

7.  High density lipoprotein particle size distribution in cord blood.

Authors:  P Kherkeulidze; J Johansson; L A Carlson
Journal:  Acta Paediatr Scand       Date:  1991 Aug-Sep

8.  Expression of human paraoxonase (PON1) during development.

Authors:  Toby B Cole; Rachel L Jampsa; Betsy J Walter; Tara L Arndt; Rebecca J Richter; Diana M Shih; Aaron Tward; Aldons J Lusis; Rhona M Jack; Lucio G Costa; Clement E Furlong
Journal:  Pharmacogenetics       Date:  2003-06

9.  Maternal chronic hepatitis B virus is implicated with low neonatal paraoxonase/arylesterase activities.

Authors:  Kleopatra H Schulpis; Anastasia Barzeliotou; Miltiadis Papadakis; Alexandros Rodolakis; Aris Antsaklis; Ioannis Papassotiriou; George D Vlachos
Journal:  Clin Biochem       Date:  2007-11-07       Impact factor: 3.281

10.  Lipoprotein concentrations in newborns are associated with allelic variations in their mothers.

Authors:  Olivier S Descamps; Monique Bruniaux; Pierre-Francois Guilmot; René Tonglet; Francis R Heller
Journal:  Atherosclerosis       Date:  2004-02       Impact factor: 5.162

View more
  4 in total

Review 1.  Recent progress in the genetics and epigenetics of paraoxonase: why it is relevant to children's environmental health.

Authors:  Nina Holland; Daneida Lizarraga; Karen Huen
Journal:  Curr Opin Pediatr       Date:  2015-04       Impact factor: 2.856

Review 2.  Human paraoxonase 1 as a pharmacologic agent: limitations and perspectives.

Authors:  Priyanka Bajaj; Rajan K Tripathy; Geetika Aggarwal; Abhay H Pande
Journal:  ScientificWorldJournal       Date:  2014-10-20

3.  A Multi-Omics Analysis of PON1 Lactonase Activity in Relation to Human Health and Disease.

Authors:  Boštjan Petrič; Tanja Kunej; Aljoša Bavec
Journal:  OMICS       Date:  2020-12-11

Review 4.  Fetal High-Density Lipoproteins: Current Knowledge on Particle Metabolism, Composition and Function in Health and Disease.

Authors:  Julia T Stadler; Christian Wadsack; Gunther Marsche
Journal:  Biomedicines       Date:  2021-03-30
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.